Virta Health is on a mission to reverse type 2 diabetes and provide sustainable weight loss solutions through a life-changing approach to care. They aim to help people regain their health and live a better life by addressing the root causes of metabolic conditions.

Pioneering diabetes reversal for 100 million people, and setting a new standard of medical care for people living type 2 diabetes, prediabetes, or obesity.

Just a few short years ago, type 2 diabetes reversal wasn’t considered possible. Fast forward to today, and Virta’s pioneering efforts have made it mainstream, while revolutionizing healthcare delivery in the process. Still, there’s so much more to be done! If you’re ready to redefine what’s possible, transform our industry, and reinvent healthcare for good, we invite you to join our cause at Virta!

We have opportunities for software engineers, health coaches, scientists, clinicians, and more. Visit https://www.virtahealth.com/careers to see our full list of open roles.

See how Virta is transforming healthcare by developing the next generation of healthcare technology. Check out our technical blog at https://www.virtahealth.com/health-tech.

Join our Talent Community at https://tinyurl.com/virtatalentcommunity to stay connected!

Caffeinated Capital

StartUp Health

Venrock

Obvious Ventures

Playground Global

Creandum

Tim Kendall

Sequoia Capital Global Equities

Tiger Global Management

Virta Health

Here’s what you need to know about GLP-1 Drugs. How they work, the benefits, and the potential downsides: 

“I learned about Virta through my health insurance provider Cigna Healthcare which is administered by National International Association of Machinists Benefit Trust Fund (NIAM). 

When I received the letter, I could not refuse the recommendation of my health insurance. I’m tired of taking medication and I know it’s expensive for them.” 

- Tillie #RoadToReversal 

https://lnkd.in/g2F4Jeqm

Congratulations to our Senior Recruiting Manager, Brady, on the new addition!

Join our Talent Community to stay up to date: https://lnkd.in/dUU93iZc  

To understand how the GLP-1 cost crisis is evolving and how health plan leaders are approaching it, Virta surveyed 60 Chief Medical Officers, Chief Pharmacy Officers and actuarial leaders.

Executives from plans representing millions of covered lives shared their predictions for growth, their biggest concerns and what they’re doing to mitigate the risk at their organization.

Join our free webinar featuring Virta's Jonathan Pearlstein and Steve Hastings on Thursday, February 29th at 10am PT, to get the latest data, including:

- Why GLP-1 growth outpaced expectations in 2023 and why half of execs predict it will be a top 3 drug class in 2024

- How lifestyle programs have factored in to GLP-1 strategies and why investment is on the rise

- What is working to protect organizations from surging GLP-1 costs

Register at:  

COM:VIRTAHEALTH

Virta Health

Analysis Not Available